|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/12/22 Acro Biomedical Co., Ltd. 10-Q 6/30/22 37:1.7M Pubco Reporting … Inc/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 456K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 17K
3: EX-32.1 Certification -- §906 - SOA'02 HTML 13K
9: R1 Cover HTML 61K
10: R2 Balance Sheets HTML 99K
11: R3 Balance Sheets (Parenthetical) HTML 30K
12: R4 Statements of Operations (Unaudited) HTML 74K
13: R5 Statements of Changes in Stockholders' Equity HTML 54K
(Unaudited)
14: R6 Statements of Cash Flows (Unaudited) HTML 66K
15: R7 Organization and Description of Business HTML 18K
16: R8 Summary of Significant Accounting Policies HTML 25K
17: R9 Going Concern HTML 16K
18: R10 Related Party Transactions HTML 16K
19: R11 Leases HTML 26K
20: R12 Stockholders' Equity HTML 19K
21: R13 Concentration HTML 15K
22: R14 Subsequent Events HTML 15K
23: R15 Summary of Significant Accounting Policies HTML 39K
(Policies)
24: R16 Leases (Tables) HTML 26K
25: R17 Summary of Significant Accounting Policies HTML 14K
(Details Narrative)
26: R18 Related Party Transactions (Details Narrative) HTML 27K
27: R19 Leases (Details) HTML 14K
28: R20 Leases (Details 1) HTML 18K
29: R21 Leases (Details 2) HTML 21K
30: R22 Leases (Details Narrative) HTML 20K
31: R23 Stockholders' Equity (Details Narrative) HTML 33K
32: R24 Concentration (Details Narrative) HTML 24K
35: XML IDEA XML File -- Filing Summary XML 58K
33: XML XBRL Instance -- acro_10q_htm XML 302K
34: EXCEL IDEA Workbook of Financial Reports XLSX 46K
6: EX-101.CAL XBRL Calculations -- acro-20220630_cal XML 80K
8: EX-101.DEF XBRL Definitions -- acro-20220630_def XML 112K
5: EX-101.LAB XBRL Labels -- acro-20220630_lab XML 344K
7: EX-101.PRE XBRL Presentations -- acro-20220630_pre XML 253K
4: EX-101.SCH XBRL Schema -- acro-20220630 XSD 63K
36: JSON XBRL Instance as JSON Data -- MetaLinks 150± 201K
37: ZIP XBRL Zipped Folder -- 0001640334-22-001752-xbrl Zip 85K
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of Acro Biomedical Co., Ltd. (the “Company”) on Form 10-Q for period ended June 30, 2022 as filed with the Securities and Exchange Commission on the date hereof, I, Pao-Chi Chu, chief executive officer and chief financial officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
|
|
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: August 12, 2022 | By: | /s/ Pao-Chi Chu |
|
|
|
|
| |
|
|
| Chief Executive Officer and Chief Financial Officer (Principal Executive Officer and Principal Financial Officer) |
|
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/12/22 | None on these Dates | ||
| For Period end: | 6/30/22 | |||
| List all Filings | ||||